Breaking News: Link 142

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 142

 

The U.N. at 70: Impressive Successes and Monumental Failures 

A commitment to improve global health information 

Seismic change at WHO? Expert Committtee adds trastuzumab, imatinib, daclatasvir, sofosbuvir, bedaquiline and delaminid to EML 

In ‘Huge’ Move, WHO Adds Key Hepatitis C, Cancer, TB Drugs To Essential Medicines List 

L’OMS accende i riflettori sui problemi legati alla mancata vaccinazione 

EUROPEAN REPORT ON DEVELOPMENT 2015 

Ratification Of Marrakesh Treaty For The Blind Postponed In Europe? 

EU development finance needs ‘completely new approach’, report says 

Data for Development 

MEPs unimpressed with Commission’s ISDS proposal 

La Regione Toscana partner per l’Italia del progetto World Wide Views sul clima e l’energia 

MEDICAL RESEARCH: HOUSTON, WE HAVE A PROBLEM, WHY THEY DON’T WANT YOU TO SEE IT? 

Why is the number of poor people in Africa increasing when Africa’s economies are growing? 

Health gap between urban rich and poor getting worse 

Bill and Melinda Gates move to bolster global health basics 

EBOLA RESPONSE – LESSONS LEARNED 

Ebola end in sight as weekly infections drop to single figures 

Ora il virus Ebola cambia forma: vietato abbassare la guardia 

Global partnerships key to eradicating TB 

The Health Reform Landscape: Medicare Payment Scorecard 

The asbestos paradox: global gaps in the translational science of disease prevention 

WHO warns of burgeoning obesity crisis in Europe 

Food Security in Developing Countries: Is There a Role for the WTO? 

Expo Milano 2015 – A Taste of Europe’s Sustainable Food Production Program 

The Italian Cooperation at Expo 2015 

A biodiverse world. Agro-biodiversity in a changing world 

India’s Chilling Crackdown 

 

HIV and TB in Prisons

Prisons are often a catalyst for the outbreak of contagious disease epidemics. Prisoners are, therefore, much more likely to contract and spread many diseases. This article will explore why prisoners are at greater risk for contracting certain infections, why this inequity should not be tolerated, and how this issue is innately connected to the public health of the general population. There will be a follow-up article that explores current programs that seek to significantly minimize the impact of communicable and infectious diseases and how the causes of increased susceptibility of prisoners can be mitigated

Corie Leifer

by Corie Leifer*, MSc.

Supervised by Anke van Dam, MD

AIDS Foundation East-West (AFEW)

HIV and TB in Prisons

 

Communicable and Infectious Diseases in Eastern Europe and Central-Asia

Despite new technology and advances in treatments and medicines, the growth in the number of new HIV infections in Eastern Europe and Central Asia (EECA) remains steady. In Europe, between 2004 and 2013 the number of new HIV infections increased 80% from 76,000 new cases to more than 136,000. Of these 136,000 new infections in Europe, 105,000 were in EECA. In EECA in this same nine-year period, the number of new HIV cases has doubled. Furthermore, this region has the highest prevalence of injecting drug users. There is a well-established connection between injecting drug use and contracting HIV. In fact, of the 3.7 million injecting drug users in the region, roughly one-quarter are believed to be infected with HIV. Tuberculosis is also prevalent in this region. More and more cases of multi-drug resistant Tuberculosis are diagnosed. This makes that TB has become one of the causes of death in this region. More than 95% of deaths due to TB occur in low- and middle- income countries.

Communicable and Infectious Diseases in Prisons in EECA

The prevalence of HIV in prisons is estimated to be between 2 and 50 times greater than that in the general population. Within EECA, Kazakhstan has the lowest HIV prevalence among prisoners with 2% infected. Tajikistan has the highest rate of HIV infection in prisoners in the region with nearly 7%, accounting for nearly one-fifth of all people infected with HIV in Tajikistan. Additionally, the risk of contracting TB in prison is estimated at 60–100-times higher compared than outside of prison. Within the prison population, there is an increased rate of mortality due to TB infection when compared with that of the general population.

Aids Foundation East-West (AFEW) is one of the few international networks that works in prisons in EECA to help reduce the burden of infectious and communicable diseases such as HIV and TB. As experts in prison health in this region, AFEW continues to play an integral role in developing the necessary links between governmental and civil society organizations to improve the health of prisoners.

Why Does It Matter?

Prison health has no priority on the different, political, global, agenda’s.. It is often assumed that the imprisonment is a result of one or more bad decisions. In many countries, people may be imprisoned for years while awaiting a trial, only to be found innocent of the crime for which they are charged. Regardless of the reason for imprisonment, the punishment of a prisoner should revolve around the lack of freedom, not the lack of healthcare.

Human Rights

It states in the Constitution of the World Health Organization that “The enjoyment of the highest attainable standard of health is one of the fundamental rights of every human being”. Whether or not a prisoner belongs behind bars is completely irrelevant to, and should not impede upon, his or her human rights. In 2006, the Council of Europe declared that prison conditions must never infringe upon human dignity. Prisoners do not have the same option as the general population to search for a practitioner with whose services they are happy. Prisoners have no other choices in regards to their medical health except to use the medical staff and resources provided by the prison. Therefore, it has been decided by the Council of Europe that “states are under the obligation to respect the right to health by… refraining from denying or limiting equal access for all persons, including prisoners or detainees … to preventive, curative and palliative health services”. In fact, due to the importance of this responsibility, governments can be held legally responsible “for failure to prevent all forms of avoidable health impairment or damage to the well-being of its prisoners”. Within the context of health, prisons should provide enough space, light, fresh air, clean sanitary facilities, clothing, heating, and adequate nutrition.

Impact on General Population

Prisoners are rarely imprisoned for life. There is a high turnover in prisons, with many prisoners only spending days, weeks, or months behind bars. Before their imprisonment, prisoners are members of the general population. After their release, they return to the community. There are also members of the general population who work in prisons, have relationships with prisoners, or work with prisoners who participate in outside work placement situations. Therefore, the exchange of diseases between the prison population and the general population is inevitable. There are many examples of outbreaks of TB and HIV in prisons tied to increased prevalence of the respective disease in the community in Thailand, Lithuania, Latvia, England, and other places around the world. “Major HIV outbreaks occurred among prisoners in Glenochill, Scotland in 1993 and in the Alytus prison in Lithuania in 2002.”

Causes

Before tackling any issue, public health or otherwise, the source of the issue must be understood. Therefore, disease management must first address the how the disease is transferred from one person to another and then investigate how the factors fueling the spread of the disease can be diminished.

HIV and TB have different means of transmission. HIV is spread through the exchange of infected blood or semen. The main methods of transmission are unprotected (voluntary or involuntary) sexual intercourse or through the sharing of needles, which may be used for injecting drugs or applying homemade tattoos. TB is spread much easier through merely inhaling the bacteria.

There are many factors that contribute to the rapid spread of communicable and infectious diseases through prisons. A lack of many factors also contributes to the devastation caused by the disease(s).

Lack of Proper Facilities

Prisons are often lacking appropriate facilities to ensure the health and safety of the prisoners that it houses. It is especially problematic in places where incarceration is punishment for minor crimes such as petty drug offenses because of an increase in the number of prisoners. In many places around the world, the prison population is increasing, but the capacity of prison services is not growing at the same rate. “While overcrowding is a health issue all over Europe, the situation is particularly serious in some of the countries of EECA, where overcrowding goes hand in hand with health problems.” The overcrowding not only leads to a lack of personal space which will inevitably lead to the spread of contagious diseases, but it also overwhelms the plumbing and sanitation services and water and food supply. Additionally, the poor ventilation, minimal access to clean drinking water, non-existent nutritional considerations, and lack of lighting and heating contribute greatly to the susceptibility of prisoners to contracting contagious diseases. Ukraine, for instance, fulfills more than 120% of their capacity for housing prisoners.

Lack of Structure, Procedures and Oversight

In many countries, there is little to no link or alignment of prison health services with national health services or national efforts to address communicable and infectious diseases. Often prison health services operate parallel to, not in conjunction with, national health programs. This creates duplicated efforts, a lack of consistency, and incomplete information. By integrating prison health services and national health services, prisons would be better able to provide medical care comparable to those provided to the general population, the importance of which is discussed above. In fact, prison health is not even regulated by the Ministry of Health in many countries; rather it falls under the jurisdiction of the Ministry of Justice.
Not only are prison health services not aligned with national health services, but in many cases they also do not maintain the same standards and regulations. There are not clear policies or guidelines regarding healthcare protocols, job descriptions of health personnel or quality evaluation. There are also few, if any, infection control measures, medication administration protocols, or systematic screening, counseling or testing for communicable and infectious diseases. This can lead to disconnected, inefficient health services and a decreased quality of care. Without the standards and procedures, clinical decisions may be guided by opinions and feelings, rather than medical criteria. Furthermore, confidentiality and safety may be compromised, as well as the health of the patient.
The lack of standards and protocols leads to poor record keeping, which in turn leads to poor evaluation, quality, and health management. There is minimal, if any, record keeping, monitoring, or evaluation of the health of prisoners. There is a lack of baseline information, morbidity statistics, and status update information. There are not systemized and uniform procedures and forms used for collecting health information. Without this information and standardization, tracking the progress of the health of prisoners is nearly impossible. As a result, prison health statistics are mainly absent from the health data provided by most countries.

Lack of Harm Reduction Measures

Injecting Drug Use (IDU) remains the main cause of the spread of HIV in EECA. This is the case for both the general population and for prisoners. In fact, injecting drug use is the cause of 50–70% of cumulative HIV cases in the region. In prison specifically, this phenomenon is made worse by needle sharing. In Central Asia, it is estimated that 5-25% of prisoners have drug dependence issues and as many as 70% share injecting tools.
Drug users and prisoners are often overlapping populations. There are two main reasons for this, and each exacerbates the other. The first reason is that drug users are overrepresented in prisons and detention centers. This is due to the illegality of drug use. For instance, in Georgia, even trace amounts of drugs in a used syringe can be enough to lead to an arrest. Such strict laws almost guarantee that drug dependence will lead to criminal prosecution. Between 5% and 38% of prisoners in Europe report injecting drugs prior to imprisonment. The second reason that prisoners are more likely to use drugs is due to their incarceration. In fact, between 2% and 56% of prisoners surveyed reported injecting drugs while in prison. Drugs remain available in prisons, despite the confining circumstances. However, safe injecting tools are not as widely available. This leads to an inevitable situation of many people using the same needle to inject drugs. Drug use can lead to incarceration, and incarceration can lead to drug use. As is clear, this is a cycle that is difficult to break.
There is a lack of Needle Syringe Exchange Programs, and therefore clean needles in prisons. Additionally, there is minimal Opioid Substitution Therapy (OST) available to prisoners. “As of 2010, 74 countries worldwide had opioid substitution therapy available in the community. Of these countries, only 39 also had this therapy available in prisons.”

Lack of Proper Medical Care

Limited medical care within the prison setting is a multi-faceted problem. As already discussed, without procedures and standards for screening, counseling, or testing, prisoners may be exposed to avoidable health risks. Additionally, medical care is often not complete, timely, comprehensive or individualized.
There are few to no provisions made to continue to ensure that healthcare and treatment is sought by and provided to prisoners who have recently been released. This is despite the fact that continuity of care has been proven to be essential to ensuring treatment adherence and therefore helping prevent drug-resistant strains of disease from developing.
The absence of proper medical care is also a product of a lack of well-trained personnel. Working within the prison system is often regarded as not prestigious or possibly unsafe. There is minimal training provided and many employees are young and do not have extensive professional experience. This might foster an incompetent workforce and deter highly skilled professionals.
Proper medical care includes offering “access at the right time to a general practitioner or to specialized care.” Specialized care includes reproductive healthcare for women. Even though women make up a small percentage of the prison population, the rate of infection with HIV for incarcerated women is often higher than that in the male prison population. This is in part due to an increased likelihood of drug dependence and injecting drugs in imprisoned women when compared with imprisoned men. In prisons in many countries there are no provisions taken to provide qualified specialized care for female prisoners.

Conclusion

Prison health is public health. Unlike the prisoners, the spreading of a contagious disease is not confined by the walls of the prisons. It is, therefore, not only in the best interest of the prisoners to provide them with healthcare, but it is also in the best interest of society. This is not only the most humane approach, but also the most cost-effective and socially beneficial. In health issues, it is almost always the case that prevention is the most cost-effective method to disease management. Preventing the spread of disease is a much more feasible task than managing an already prolific outbreak. Prevention measures include addressing the “factors related to the prison infrastructure, prison management and the criminal justice system (that) contribute to vulnerability to HIV, TB and other health risks in prisons.” Prisoners have an increased probability of contracting a contagious disease due, in part, to the lack of hygiene, proper medical care, and personal space. Therefore, the epidemics cannot be brought under control until at least some of the many contributing factors are addressed.

 

Citations

http://www.euro.who.int/en/health-topics/health-determinants/prisons-and-health/prisons-and-health

Prison and Health Data and Statistics. World Health Organization, 2010. http://www.euro.who.int/en/health-topics/health-determinants/prisons-and-health/data-and-statistics accessed March 25, 2015.

http://aidspan.org/gfo_article/improvement-hivtb-prevention-treatment-and-care-prisons

http://www.euro.who.int/en/media-centre/sections/press-releases/2014/europes-hiv-response-falls-short-in-curbing-the-epidemic-80-more-new-hiv-cases-compared-to-2004

http://ec.europa.eu/health/sti_prevention/docs/ev_20130527_co05_en.pdf

Get the Facts. Common Sense for Drug Policy, 2012. http://drugwarfacts.org/cms/chapter/eeca#sthash.narlwsn.dpbs accessed March 25, 2015.

http://www.euro.who.int/__data/assets/pdf_file/0005/126473/e94437.pdf?ua=1

http://www.unodc.org/documents/hiv-aids/publications/Prisons_and_other_closed_settings/Good-governance-for-prison-health-in-the-21st-century.pdf

http://www.who.int/mediacentre/factsheets/fs104/en/

http://www.avert.org/prisoners-hivaids.htm

http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/policy/policy-guidance-for-key-populations-most-at-risk2/hiv-in-prisons

http://www.prisonstudies.org/highest-to-lowest/occupancy-level?field_region_taxonomy_tid=All

 

——————————————————————————–

*Corie Leifer (Office Manager since January 2013), was born in 1981 in Connecticut, USA. After earning a bachelor degree in communications and another in nursing in the United States, she moved to the Netherlands in 2011 to earn a Master of Health Science degree with a focus on International Public Health from Vrije Universiteit in Amsterdam. During this study, Corie completed her internship at AFEW and subsequently joined AFEW as Office Manager. As a research intern, she investigated the use of SMS campaigns to reduce the spread of HIV/AIDS. Corie has international marketing and communications experience, having worked at Operation Smile, Inc. and Trader Publishing Company prior to returning to school. Corie is also a Registered Nurse licensed in the Commonwealth of Virginia, USA.

Breaking News: Link 141

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 141

 

Global Fund Launches Human Rights Complaints Procedure

Knowledge for effective action to improve the health of women, children and adolescents in the post-2015 era: a call for papers

Harsh criticism of its Ebola response pushes WHO to open up, do better

Health Care Equity Needed To Fight Ebola

Ecco perchè Ebola non è ancora finito

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

Measles: From Washington to Lagos via Berlin – no passport required

Chagas Disease in Colombia: An opportunity to lead the way towards change

No ‘plan C’ drugs available, malaria progress threatened

ASMQ FDC registered in Cambodia and Thailand

Accurate information as a tool to decrease HIV test refusals in research studies

MSF vaccinate 50,000 children against pneumonia in Gambella, Ethiopia

A Fair Shot: Bringing down the price of vaccines 

Strategies to increase the demand for childhood vaccination in low and middle-income countries: a systematic review and meta-analysis

Vaccini, lo studio ISS: “In Italia centinaia di morti in più”

Worldwide country situation analysis: response to antimicrobial resistance

A bid to stop superbugs in the EU

Farmaci contraffatti: in Italia un traffico da milioni di euro

EUROPEAN PARLIAMENT TO VOTE ON A TTIP RESOLUTION

Support the bill to reinstate the NHS

EU health agencies to get knuckles rapped

Time for global health to zoom in on migration

It’s Time For Value-Based Payment In Oncology

When Health Care Transformation Fails

Health Cooperation In The New U.S.-Cuban Relationship

Income Inequality Is Costing the U.S. on Social Issues

BRICS to push cooperation on climate change

The healthy food environment policy index: findings of an expert panel in New Zealand

How can grassroots aid programmes influence the wider system?

Breaking News: Link 140

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 140

 

7 Hopeful Climate Stories from around the Globe

WHO leadership admits failings over Ebola, promises reform

Ban urges ‘bold changes’ to aid action as States prepare for World Humanitarian Summit

Health Care Reform And The Trap Of The “Iron Law”

Embedding Civil Legal Aid Services In Care For High-Utilizing Patients Using Medical-Legal Partnership

Narrative Matters: On Our Reading List

The future of Land Matters for development

Access to education for 1 million children improved through 10-year UNICEF and ING partnership

EU states told to tackle health challenges of migrant emergency

Development MEPs urge EU countries to stick to foreign aid commitments

EU must pull its weight to help create a better global financial system

Canada creates a bilateral Development Finance Institution: will Australia follow suit?

Competition Analyses of Licensing Agreements: Considerations for Developing Countries under TRIPS

China and UHC in Africa

The Cost and Cost-Effectiveness of Alternative Strategies to Expand Treatment to HIV-Positive South Africans: Scale Economies and Outreach Costs

A Public Health Approach to Hepatitis C Control in Low- and Middle-Income Countries

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

World Malaria Day 2015: Progress at risk with spread of drug resistance

Substandard drugs, not fakes, undermine fight against malaria

Ebola outbreak likely driving malaria deaths: study

New website shows Swiss leadership in the fight against Malaria

UAEM Grades US Universities On Research For Neglected Diseases. Spoiler Alert – There’s Room For Improvement

IBFAN Italia festeggia la Giornata della Terra pubblicando il dossier “Formula For Disaster”

Formula for Disaster: Weighing the Impact of Formula Feeding Vs Breastfeeding on Environment

Formula for Disaster: come il latte artificiale inquina il mondo

As Vaccination Rates Dip, Parents Walk A Tightrope Between Doubt And Risk

Open, Online Database Of Clinical Trials Planned

Human Rights Reader 360

Global Food Security Act brings parties together in committee markup

Like Taking Candy From A Baby? The Not-So-Easy Policy Landscape For Cutting Added Sugars In America

Breaking News: Link 139

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 139

 

From The WHO: Preventing The Next Ebola 

Ebola outbreak still a global emergency despite significant drop in cases – UN health agency 

World Bank must lead efforts to raise $1.7 billion to improve Ebola-hit countries’ health care 

New 2015 edition of World Development Indicators shows 25 years of progress, but much left to do 

Europe’s Biggest Economies Continue to Deny Aid to the World’s Poorest, Despite 2015 Deadline

Future of Food: World Bank Outlines Action Agenda for Food System to Help End Poverty and Hunger 

Richard Lugar: ‘Kudos’ on US food aid reform hearing 

World Bank and EIB chiefs call for greater financial engagement and technical cooperation to fight climate change 

AfDB fast tracks to join Green Climate Fund’s newly accredited agencies to channel more climate finance to the continent 

Health can tackle (and measure) inequities 

“Equity, sustainability, dignity”: a proposal for a tripartite post-2015 motto 

Human Rights Reader 359 

Wave Of Protests Against TTIP, CETA, TISA 

MSF response to Indian Prime Minister’s visit to Germany and EU India FTA negotiations 

Don’t Keep the Trans-Pacific Partnership Talks Secret 

Experts Debate Medicines Access In South Africa And Beyond 

New Cures Require New Pricing Policies 

KEI statement to WHO 20th Expert Committee on the Selection and Use of Essential Medicines 

KEI and Public Citizen ask the NIH for safeguards in patent license for HCV drug 

The Payment Reform Landscape: Impact On Consumers 

If The ACA Were Repealed, Just What Would Replace It? 

May The Era Of Medicare’s Doc Fix (1997-2015) Rest In Peace. Now What? 

The Quality Tower Of Babel 

Salute e Movimenti, 1978-2015: recuperare la memoria storica per guardare al futuro 

I medici inglesi dicono basta al mercato 

Breaking news: CROI 2015 Update 

How the Global Drug Facility (GDF) Works to Reduce Prices of MDR-TB Drugs

Stop TB Partnership’s Global Drug Facility (GDF) was established in 2001, with the aim of using donor funding to consolidate demand from different countries and negotiate affordable prices for quality-assured anti-tuberculosis drugs. 
Today, as one of the main players in the complex global market for TB drugs, the GDF plays a crucial role in not only shaping drug supply, but also in reducing the price of medicines

Kaspars Lunte jpeg

by  Kaspars Lunte

Team Leader Sourcing and Special Projects, Global TB Drug Facility
Stop TB Partnership Secretariat/UN Office for Project Services

How the Global Drug Facility (GDF) Works to Reduce Prices of MDR-TB Drugs

 

One of the central objectives of The Global Plan to Stop Tuberculosis, a strategy document launched by the Stop TB Partnership every five years, is universal access to high-quality care for all people with tuberculosis.

Affordable drugs to fight TB and effective systems to provide treatment are important to increase cure rates. However, disease control depends, not only on the existence of curative treatment, but also on sustainable drug supply, which is ultimately mediated by the pharmaceutical market.

Countries often have limited experience in securing the best possible prices for quality assured drugs and have little negotiating power since they are not able to consolidate drug purchases into large volumes. This is especially true of the medicines needed for multidrug-resistant tuberculosis (MDR-TB), where treatment is complex and can last two years or more. In addition, these medicines are much more expensive than those for drug-sensitive tuberculosis.

The importance of usage of quality assured medicines as opposed to usage of drugs of unknown quality, is also underestimated by some countries.

Stop TB Partnership’s Global Drug Facility was established in 2001, with the aim of using donor funding to consolidate demand from different countries and negotiate affordable prices for quality-assured anti-tuberculosis drugs.

Over the last decade or more, the GDF has played a crucial role in not only shaping drug supply, but also in reducing the price of medicines. Today, as one of the main players in the complex global market for TB drugs, GDF occupies a unique position. In 2011, it supplied enough drugs to treat 35% of publicly notified cases of tuberculosis worldwide and an estimated 24% of all incident cases.

Today, access to quality-assured drugs is promoted by key stakeholders including WHO’s Medicines Prequalification Programme, by the Global Fund to Fight AIDS, Tuberculosis and Malaria, other donors and the GDF.

However, despite the existence of international quality-assurance standards, TB drugs are often either substandard or counterfeit. Unsurprisingly, recent studies show that the substandard and falsified drugs readily available on the private market have probably contributed to the development of drug-resistance in low- and middle-income countries.

Although patents have expired on many TB drugs, low-income countries with a high disease burden have limited power in negotiating on an individual basis for cheaper treatment. Disease control is therefore profoundly influenced by the functioning of the TB drug market, particularly in resource-poor settings with a high disease burden.

Further, second-line treatment for MDR-TB involves more protracted and complex chemotherapy and can cost a hundred times more than treating drug-sensitive tuberculosis.

In such an environment, a defining feature of the GDF model is role that international quality-assurance standards play in its operation. These are embedded in overall quality management so that stringent public procurement standards can be met.

However, some manufacturers concerned about quality, may find that the benefits of acquiring international quality-assurance certification do not necessarily outweigh the investments needed to meet these standards. However, by creating a large, stable market, a mechanism such as the GDF, provides clear incentives for a supply of drugs that meet international quality-assurance standards. In 2012, the value of this market for tuberculosis drugs exceeded 109 million United States dollars (US$).

In 2013, as in previous years, the GDF reduced the price of the second-line drugs it supplies for the treatment of MDR-TB. This has resulted in a significant decrease in the overall cost of treatment. Between 2011 and 2013, for a 24-month treatment course for one of the most expensive medicines combination to treat MDR-TB, the cost of treating one patient decreased by up to 26% – from US$ 7890 to US$ 5822. (Costs were calculated based on nominal prices obtained from the Global Drug Facility, without adjusting for either inflation or exchange rates.)

In 2015, GDF slashed the price of Cycloserine – a key medicine to treat multi-drug resistant TB (MDR-TB) – by 55% compared to the previous year. This price reduction is expected to save up to US$ 22 million annually, enabling treatment for more people living with MDR-TB for the global donors. (In fact, the new GDF price for cycloserine indicates a reduction of up to 68% compared to the price of five years ago.)

The price reductions obtained by the GDF were secured not only because of its continuing efforts to consolidate orders, but also creating true partnership spirit with our suppliers.

The expansion of the supplier base for internationally quality assured, second-line drugs for MDR-TB ensures competition in the drug market. This enabled the GDF to consistently secure low prices. The system of competitive and transparent bidding involving long-term agreements and the existence of the donor (UNITAID and USAID) -funded rotating stockpile also reduced prices. The MDR-TB medicines stockpile also helped decrease delivery times. Finally, the resulting drug cost savings led to an increase in the number of courses of treatment delivered for constant amount of allocated funds.

Over time, the number of suppliers of quality-assured drugs for MDR-TB has significantly increased. And previous capacity assessment has shown that production capacity can now be rapidly expanded to satisfy twice the current demand if required.

The GDF has also increased the number of courses of treatment for MDR-TB that have been delivered year on year. In 2014, the Facility delivered a sufficient quantity of various drug combinations to provide 35,000 courses of MDR-TB treatment.

GDF can indeed secure lower prices for quality assured drugs compared to those available for unregulated drugs of unknown quality on the private market. Importantly, according to published studies, GDF’s prices varied considerably less than those in the private market. This could greatly assist planning, both for countries procuring medicines and for manufacturers, who would be able to better anticipate future demand. The GDF can thus create and support identifiable, transparent markets for internationally quality-assured drugs.

Autosufficienti ‘National Food Economies’ contro la Fame nel Mondo

 Oltre 1 miliardo di persone nel mondo soffrono la fame, soprattutto in Africa. A scopo correttivo, ricostruire autosufficienza nelle 'national food economies' è l’ obiettivo finale. Ne sono strumenti l’aumento dei fondi per la ricerca e lo sviluppo agricolo, la diversificazione della produzione interna, la promozione della vendita diretta da produttore a consumatore, la realizzazione di riserve alimentari nazionali, la distribuzione equa e lo stop agli espropri dei terreni agricoli, il controllo sulle importazioni, l’abolizione dei dazi intra-Africa, la lotta alla corruzione. A livello internazionale, queste misure devono implementarsi con la realizzazione di riserve alimentari sovranazionali e di regolamenti per il controllo dei volumi alimentari esportabili in Africa da parte dei Paesi ricchi. Solo così sarà possibile contrastare gli effetti negativi delle politiche neo-liberali che minano l’autosufficienza alimentare, del neo-colonialismo agricolo e dello sfruttamento terriero per bio-carburanti, delle speculazioni sui titoli “future” delle materie prime alimentari, della monopolizzazione dei mercati da parte delle compagnie multinazionali occidentali

MINOLTA DIGITAL CAMERA

by  Daniele Dionisio

PEAH – Policies for Equitable Access to Health 

Autosufficienti ‘National Food Economies’ contro la Fame nel Mondo

 

La salute costituisce obiettivo trasversale a tutti gli Obiettivi di Sviluppo del Millennio. L’Organizzazione Mondiale della Salute (WHO) definisce, infatti, la salute non solo come assenza di infermità e malattia, ma anche quale stato di benessere fisico, mentale e sociale.
Salute e sviluppo economico sono, pertanto, embricati e non può esservi salute senza eliminazione della fame che attanaglia i Paesi poveri ed impedisce l’ accesso a cure e terapie essenziali. Complici la recessione globale e l’instabilità climatica, nel 2008 il prezzo della farina aumentò del 120%, mentre il valore di mercato del riso cresceva del 75%. In Bangladesh un sacco di riso da 2 chili erodeva quasi la metà del reddito giornaliero di una famiglia povera, mentre la Banca Mondiale (WB) prevedeva che oltre 20 nazioni dell’Africa avrebbero visto peggiorare la loro bilancia commerciale per una cifra corrispondente ad almeno l’ 1% del PIL a causa dell’aumentato costo delle importazioni dei generi alimentari.
Oggi, seppure lontani dai record del 2008, i prezzi degli alimenti base spesso restano inaccessibili e le persone che nel mondo soffrono la fame sono oltre 1 miliardo, soprattutto in Africa.
Certo, occorrono più fondi per la fame nei Paesi poveri, ma non possono bastare perché, al di là dei volumi, qualsiasi soluzione monetaria resta di fatto limitata all’emergenza. Piuttosto, sono necessari cambiamenti drastici delle prassi internazionali e delle politiche commerciali e governative principalmente in causa:

Politiche neo-liberali che minano l’autosufficienza dei Paesi nel settore produttivo alimentare
Negli ultimi decenni Banca Mondiale (WB), Fondo Monetario Internazionale (IMF) e Organizzazione Mondiale del Commercio (WTO) hanno condotto politiche di disincentivazione alla autonomia produttiva dei Paesi in via di Sviluppo (PVS) e contratto il supporto monetario e gli investimenti nelle produzioni agricole locali. Contemporaneamente, le riserve alimentari nazionali sono state progressivamente dismesse perché “dispendiose”, mentre accordi WTO hanno forzato i PVS verso logiche di importazione alimentare, con ridotta tassazione degli ingressi e accettazione di volumi per almeno il 5% del consumo interno, indipendentemente dalle necessità reali. Le politiche neo-liberali hanno minato la capacità dei PVS all’auto-sostentamento, rendendoli vulnerabili alle fluttuazioni dei prezzi alimentari determinate dalle politiche dei Paesi esportatori.

Neo-colonialismo agricolo e sfruttamento terriero per bio-carburanti
Negli ultimi anni paesi come Cina, Arabia Saudita, Emirati Arabi, Corea del Sud, ma pure Gran Bretagna, Germania, India, Svezia,… insieme a gruppi di investitori privati, hanno fatto incetta di terre in Africa sub-sahariana per produrre bio-carburanti (da monocolture di palma da olio, granturco, colza, canna da zucchero, jatropha,…) e alimenti da esportare nei rispettivi paesi. In questo contesto, tecnici, amministratori, dirigenti, giungono dall’estero, mentre i locali sono spesso relegati a forza lavoro sottopagata.
Secondo la FAO, la quota di terra agricola destinata a bio-carburanti aumenterà al 2-3,5% entro il 2030 (dall’ 1% del 2006), ponendo a rischio la sorte di 60 milioni di persone nei Paesi Poveri.

Speculazioni sui titoli “future” delle materie prime alimentari
La speculazione finanziaria internazionale ha un peso determinante sull’incremento dei prezzi degli alimenti sin dall’estate 2007, inizio della crisi finanziaria USA. Le compagnie transnazionali stabiliscono unilateralmente il prezzo di acquisto dei prodotti nei Paesi di origine e il prezzo di vendita nei Paesi di importazione. Ma anche se il cibo sui mercati dei PVS è di produzione locale, lauti guadagni vanno solo alle compagnie e agli intermediari che incettano dai contadini per un’ inezia e rivendono a prezzi assai superiori.
Nonostante la produzione rimanga elevata, analisti e multinazionali, basandosi su previsioni di contrazioni di offerta, cinicamente strumentalizzano i mercati: in Indonesia, al culmine del rialzo del prezzo della soia (gennaio 2008) la Compagnia PT Cargill tratteneva 13.000 tonnellate di soia nei magazzini di Surabaya in attesa di usufruire dell’ indotto record dei prezzi. Non è da meno il potere monopolistico di catene di supermercati gonfianti all’eccesso i prezzi dei prodotti agricoli.

Monopolizzazione dei mercati alimentari da parte delle compagnie multinazionali
Le multinazionali controllano i mercati. I loro sistematici acquisti di terre spesso si associano all’allontanamento degli originari lavoratori rurali, oppure all’obbligo imposto agli stessi di produrre monocolture (cacao, tè, canna da zucchero, caffè, palma da olio) destinate esclusivamente al mercato (invece che a sfamare le proprie famiglie). Il magro compenso monetario è poi insufficiente per i prefissati ed elevati prezzi di mercato del cibo sia di produzione locale che di importazione. Così il sistema perversamente genera ulteriore povertà e fame.

QUALI RISPOSTE?
I contesti analizzati richiamano alla necessità sia di riserve alimentari sovranazionali, sia di regolamenti internazionali per il controllo e limitazione dei volumi alimentari esportabili nei Paesi poveri da parte dei Paesi ricchi. Ma richiamano, altresì, all’urgenza di partenariati e strategie condivise per:

Aumentare i fondi per la ricerca e lo sviluppo agricolo
Negli ultimi decenni i fondi per la ricerca e lo sviluppo agricolo destinati ai PVS da WB e altre Agenzie per lo Sviluppo sono diminuiti drasticamente (International Food Policy Research Institute-IFPRI). Nonostante una attuale controtendenza, anche per merito di donatori privati, molto maggiore impegno occorre e l’aumento dei fondi potrebbe non bastare se i risultati di ricerca non si traducessero, a supporto e tutela degli agricoltori e consumatori, in autosufficienti produzioni alimentari nazionali.

Ricostruire autosufficienza nelle ‘national food economies’
L’ obiettivo implica percorsi simultanei e sinergici per piani governativi finalizzati ad equità e aumento di investimenti per la produzione domestica, con particolare attenzione alle imprese agricole a conduzione familiare e di piccola-media dimensione. Ciò costituirebbe argine contro la fame tenuto conto, ad esempio, che l’85% degli africani vive in comunità rurali principalmente dedite all’ agricoltura. Coerentemente occorrono:

Diversificata produzione interna
Significa consentire ai conduttori di fattorie di scala medio-piccola una produzione agricola non solo monocolturale per l’export, bensì mista con prodotti destinati a sfamare i produttori stessi oltre che alla vendita locale del surplus da parte dei medesimi.

Vendita diretta produttore → consumatore
L’effetto calmierante di questa misura sui prezzi al dettaglio, a vantaggio dei consumatori locali, appare scontato.

Realizzazione di riserve alimentari nazionali
Dovrebbero essere a gestione statale. Servirebbero a stabilizzare i mercati domestici, destinandosi, in periodi di fecondità, il surplus ai mercati, e invece utilizzando gli stocks per le necessità interne in caso di carestie.

Distribuzione equa e stop agli espropri dei terreni agricoli
Sono urgenti riforme agrarie per l’equa distribuzione delle terre ai contadini e per l’abolizione della pratica degli espropri, con il fine ultimo che l’equità coniughi con la necessità di realizzare piena autonomia produttiva nazionale e ridurre la dipendenza dagli aiuti.

Controllo sulle importazioni
Ai Paesi poveri deve essere garantita libertà di controllo sulle importazioni a tutela della produzione interna. Allo scopo, il mantenimento di una adeguata tassazione sugli imports dai Paesi ricchi sarebbe strumentale.

Abolizione dei dazi intra-Africa
Significa promozione di libero commercio tra i vari Stati africani ed è manovra attualmente in avanzato corso di implementazione per una molteplicità di Stati membri della Comunità di Sviluppo dell’Africa Australe (SADC), del Mercato Comune dell’Africa Orientale e Meridionale (COMESA), e della Comunità dell’Africa Orientale (EAC).

Lotta alla corruzione
Nel settore specifico, essa dovrebbe includere azioni di governo contro il radicato abusivismo interno al settore pubblico nei PVS, e contro l’accaparramento e ricircolo illecito, a prezzi gonfiati, di prodotti alimentari e fertilizzanti.

 

——————————————————————————————–
FONTI
Via Campesina
Food and Agriculture Organization of the United Nations-FAO
International Energy Agency-IEA
International Food Policy Research Institute-IFPRI
GRAIN
International Centre for Trade and Sustainable Development-ICTSD
World Bank-WB
World Trade Organization-WTO
International Monetary Fund-IMF
World Health Organization-WHO

Breaking News: Link 138

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 138

Health in the post-MDG era: what “paradigm shift” are we talking about exactly?

UN post-2015 talks focus on draft sustainable development goals

Argentina’s Agricultural Trade Policy and Sustainable Development

Interrelations Between Plant Treaty, UPOV, WIPO, Farmers’ Rights – Do They Equate?

Climat ou business, un choix qui rend les entreprises schizophrènes

Amid Floods and Droughts, Coca-Cola Aims to Help India Stay Ahead of Climate Change

Stati Uniti: piano da oltre un miliardo di dollari contro le antibiotico-resistenze

Obama Action Plan Falls Short on Antibiotic Use in Animals

Farmaci blockbuster, in arrivo la “top eleven” del prossimo anno 

WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine

Ending Hunger, Global Challenge That Connects the UN & Expo 2015

Jim Kim: Poverty, not AIIB or the BRICS bank, is the enemy

How to stop worrying and love the Asian Infrastructure Investment Bank

AIIB not a threat to World Bank

Guinea: new surge in Ebola cases near the capital prompts shift in containment strategy

Moving Beyond Ebola: Rebuilding Liberia’s Health Care System

2 New Ebola Vaccines Pass Important Early Test, Researchers Say

Budget cuts and vaccine fears threaten health progress

Saving lives by making malaria drugs more affordable

Fighting TB with a Drive-in Film and Test

Testing and Treating the Missing Millions with Tuberculosis

The Perfect Proposal for the Addis Ababa Accord: Tobacco Taxes

Learning by Not Doing: Subsidy Disciplines in Services Trade

Improving Men’s Participation in Preventing Mother-to-Child Transmission of HIV as a Maternal, Neonatal, and Child Health Priority in South Africa

India’s historic Right to Education act: Why everyone should support Haq Banta Hai

A growing interest for intellectual properties in universities

World Debt Figures 2015

The Complex Effects Of The FDA’s Proposal To Regulate Laboratory-Developed Tests

Breaking News: Link 137

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 137

WHO: Public health round-up 

Lack of toilets and safe water in health-care facilities 

Tough decisions on essential medicines in 2015 

The Global Drug Facility as an intervention in the market for tuberculosis drugs 

Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility 

Tubercolosi, il bilancio è di milioni tra vittime e superstiti. Ma l’obiettivo è solo uno: sradicarla 

Press Release: Europe’s Leaders Approve Riga Declaration on TB and MDR-TB 

JOINT RIGA DECLARATION ON TUBERCULOSIS AND ITS MULTI DRUG RESISTANCE 30 – 31 March 2015, Riga, Latvia 

1 year later, can word spread faster than Ebola? 

Women’s Health is Everyone’s Health 

El Salvador: Women spread the word on food safety 

Closing The Rural Health Connectivity Gap: How Broadband Funding Can Better Improve Care 

Reverse HIPC mooted for aid liabilities 

The clock is ticking on the new development agenda 

Why the Sustainable Development Goals Matter 

Conferenza ActionAid, “Le nuove sfide per lo sviluppo sostenibile” – 7 aprile 2015, Roma 

A summary of HIV Prevention at CROI 2015 

Tailored combination prevention packages and PrEP for young key populations 

UNAIDS and WHO Breaking news: CROI 2015 update (9 April 2015, available on livestream)

FAO Council finds historic consensus on work programme and budget 

Food safety in a globalized world 

What to do about resistant bacteria in the food-chain? 

Tackling climate change – for our kids 

Human Rights Reader 358 

Inequities in postnatal care in low- and middle-income countries: a systematic review and meta-analysis 

Breaking News: Link 136

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

MINOLTA DIGITAL CAMERA

Breaking News: Link 136

A Social Contract for Global Health Investments in Times of Resilience

Global Health Transformers

Violence against women and girls guidance notes

Violence against women and girls: Evidence digest March 2015

MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week

AFTER AID: WHAT IS NEXT FOR TUBERCULOSIS & HIV IN EUROPE?

TB Alliance Announces Partnership with U.S. Fund for UNICEF to Increase Access to Impending New Child-Friendly TB Treatments

Leading medical organisations team up to bring new TB treatments to those in need

Grania Brigden: Time for a jumpstart—accelerating access to new and promising DR-TB drugs

TB: Ready, set, slow down: New and promising DR-TB drugs are grabbing headlines but not reaching patients

One year on: why Ebola is not yet over in Guinea

How Did Ebola Volunteers Know Where To Go In Liberia? Crowdsourcing!

In the Fight Against Corruption, US Government Urged to Localize Aid

How The Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions

Leaked dispute-settlement plan raises US trade concerns

Could the TTIP deal undo development gains?

TTIP: EU Officials Weigh ISDS Options as High-Level Meetings Continue

Il Transatlantic Trade and Investiment Partnership (TTIP)

TTIP e TISA. La salute in vendita

German Minister plans ‘Green Revolution’ to combat world hunger

Killing us softly

‘We are not perfect’ — EU development commissioner

HIV in Africa. Nuove strategie, nuove sfide

La classifica dei sistemi sanitari europei, secondo l’EHCI

Health Affairs Web First: Without CHIP, Sharply Higher Insurance Costs For Many Low-Income Families

Health Affairs Briefing: The Cost And Quality Of Cancer Care

Australia ready to join China-led bank, seeks clarity on governance

WHO urges mass vaccination against measles, other diseases in Ebola areas

S.O.S. morbillo: con il colpo di coda Ebola l’allerta epidemie non dà tregua